A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...

Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...

Shares of Prime Medicine ( PRME -0.25%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

Pancreatic cancer that spreads to the liver is especially difficult to treat because the liver naturally suppresses immune responses, creating an environment where cancer can evade detection and ...

These results are significant for mRNA vaccine research and ... Today, many other lipid nanoparticle-oligonucleotide formulations have been developed and are under clinical evaluation for the ...

News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: ...

Scientists unlock the potential of fenugreek-based lipid nanoparticles to improve diabetes ... validation through in vivo studies and clinical trials is required. The research mapped interactions ...

The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a CAGR of 5.2%, while the LNP services market is projec ...

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses ...